The Conversation (0)
RBC Life Sciences Receives US Patent for Formulation That Support Cognitive Function
Jan. 30, 2013 07:50PM PST
Life Science InvestingRBC Life Sciences Inc. (OTCQB:RBCL) announced that it has been given US Patent 8357422 which safeguards its dietary supplement formulation that enhances and supports cognitive function. This supplement is marketed under the label, “Neurobright.”
RBC Life Sciences Inc. (OTCQB:RBCL) announced that it has been given US Patent 8357422 which safeguards its dietary supplement formulation that enhances and supports cognitive function. This supplement is marketed under the label, “Neurobright.”
As quoted in the press release:
The basis for the patent was an 18-month controlled animal study conducted by Dr. Tres Thompson of the School of Behavioral and Brain Sciences at the University of Texas at Dallas,” said Clinton Howard, CEO. “The study showed that Neurobright increased both cognitive function and psychomotor abilities in animals.
Click here to read the full RBC Life Sciences Inc. (OTCQB:RBCL) press release.